ProAssurance Corporation
NYSE•PRA
CEO: Mr. Edward Lewis Rand Jr., CPA
Sector: Financial Services
Industry: Insurance - Property & Casualty
Listing Date: 1991-09-04
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds. The company also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Syndicate 1729 at Lloyd's of London for underwriting. It markets its products through independent agencies and brokers, as well as an internal business development team. The company was founded in 1976 and is headquartered in Birmingham, Alabama.
Contact Information
Market Cap
$1.26B
P/E (TTM)
24.8
11
Dividend Yield
--
52W High
$24.77
52W Low
$22.72
52W Range
Rank49Top 66.7%
3.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 3.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$269.64M+0.00%
4-Quarter Trend
EPS
$0.65+0.00%
4-Quarter Trend
FCF
-$13.21M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Combined Ratio Improves Consolidated combined ratio improved 2.8 points to 106.6% due to better underwriting results and reserve development.
Investment Result Rises Net investment result increased $6.033 M to $172.774 M, driven by higher average book yields in fixed maturities.
Strong Prior Year Reserves Recognized $90.3 M net favorable prior accident year reserve development, primarily from MPL and MedTech lines.
Non-GAAP Income Jumps Non-GAAP operating income rose $33.692 M to $83.863 M, showing core operational strength improvement.
Risk Factors
Insurance Market Competition Highly competitive P&C market pressures pricing and retention, potentially reducing profits across core insurance lines.
Merger Closing Uncertainty Finalizing Doctors Company merger is subject to regulatory approvals, with uncertain timing extending past June 30, 2026.
Investment Value Volatility Fixed maturity portfolio value sensitive to interest rate shifts; current unrealized losses total $133.744 M as of 2025.
Catastrophe Loss Exposure Unpredictable natural or man-made catastrophes could exceed reinsurance protection, materially impacting financial condition.
Outlook
Target Merger Completion Continues anticipating closing the Doctors Company transaction by June 30, 2026, pending final regulatory reviews.
Underwriting Profit Focus Emphasizes disciplined underwriting and rate adequacy over market share to achieve long-term ROE target.
Leverage AI for Excellence Committed to continuous improvement using AI and data science to enhance risk selection and claims workflows.
Manage Investment Portfolio Investment strategy focuses on maximizing current income while maintaining appropriate credit risk and short-to-medium duration.
Peer Comparison
Revenue (TTM)
$5.34B
$3.20B
$1.52B
Gross Margin (Latest Quarter)
100.0%
88.4%
87.8%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| SIGI | $4.47B | 9.6 | 13.6% | 6.0% |
| BFC | $1.46B | 17.9 | 11.3% | 2.7% |
| DCOM | $1.41B | 12.5 | 7.7% | 2.4% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
0.2%
Moderate Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
25%
Cash Flow Needs Attention
Deep Research
Next earnings:May 4, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data